| pubmed-article:9108882 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C0746319 | lld:lifeskim |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C0812425 | lld:lifeskim |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C1515985 | lld:lifeskim |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C0441790 | lld:lifeskim |
| pubmed-article:9108882 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:9108882 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9108882 | pubmed:dateCreated | 1997-4-28 | lld:pubmed |
| pubmed-article:9108882 | pubmed:abstractText | The prognostic significance of primary tumor DNA-ploidy and S-phase fraction (SPF) was evaluated in patients treated with androgen ablation for regionally localized node-positive prostate cancer. | lld:pubmed |
| pubmed-article:9108882 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9108882 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9108882 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9108882 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9108882 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9108882 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9108882 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:9108882 | pubmed:issn | 0270-4137 | lld:pubmed |
| pubmed-article:9108882 | pubmed:author | pubmed-author:WuC SCS | lld:pubmed |
| pubmed-article:9108882 | pubmed:author | pubmed-author:PollackAA | lld:pubmed |
| pubmed-article:9108882 | pubmed:author | pubmed-author:TerryN HNH | lld:pubmed |
| pubmed-article:9108882 | pubmed:author | pubmed-author:von... | lld:pubmed |
| pubmed-article:9108882 | pubmed:author | pubmed-author:ZagarsG KGK | lld:pubmed |
| pubmed-article:9108882 | pubmed:author | pubmed-author:TroncosoPP | lld:pubmed |
| pubmed-article:9108882 | pubmed:author | pubmed-author:MakA CAC | lld:pubmed |
| pubmed-article:9108882 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9108882 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:9108882 | pubmed:volume | 31 | lld:pubmed |
| pubmed-article:9108882 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9108882 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9108882 | pubmed:pagination | 21-8 | lld:pubmed |
| pubmed-article:9108882 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:meshHeading | pubmed-meshheading:9108882-... | lld:pubmed |
| pubmed-article:9108882 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9108882 | pubmed:articleTitle | The significance of DNA-ploidy and S-phase fraction in node-positive (stage D1) prostate cancer treated with androgen ablation. | lld:pubmed |
| pubmed-article:9108882 | pubmed:affiliation | Department of Radiotherapy, University of Texas, Houston, Texas. | lld:pubmed |
| pubmed-article:9108882 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9108882 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9108882 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9108882 | lld:pubmed |
